Arce-Lara, C.Arriola, E.Brunsvig, P.Carcereny, E.Domine, M.Dragnev, K.Felip, E.Garcia Campelo, R.Krebs, M.Paz-Ares, L.Ponce Aix, S.Spicer, J.Trigo, J. M.Vinolas Segarra, N.Holt, R.Micklem, D.Brown, A.Chisamore, M.Lorens, J.2025-01-072025-01-072018-10-011556-0864https://hdl.handle.net/10668/26868enAxlpembrolizumabcombinationPh II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in Patients with Advanced NSCLCconference outputopen access10.1016/j.jtho.2018.08.12511556-1380http://www.jto.org/article/S1556086418322093/pdf454014502402